Navigation Links
New Finding Suggests Safe Surgical Margins When Removing Breast Cancers

THURSDAY, Oct. 21 (HealthDay News) -- A new study suggests that in women undergoing breast-conserving surgery, removing at least 2 millimeters of healthy tissue in addition to a cancerous breast tumor is enough to lower the risk of residual cancer.

Surgeons disagree about how much of a "free margin" around a tumor is ideal, according to the study, which appears online in the November issue of IJCP, the International Journal of Clinical Practice. In the United Kingdom, about two-thirds of surgeons surveyed said they prefer a margin of 2 millimeters or more, while nearly a quarter favor removing only 1 millimeter.

"The issue is that whenever you take a lump out of someone's breast, you want to have some normal tissue around the entire malignancy. That's how the surgeon can make the statement that 'I think I got the whole thing,'" said Dr. Otis Brawley, chief medical officer of the American Cancer Society.

Surgeons often perform a procedure again if they don't think the margins are large enough, Brawley said.

In the new study, researchers from Good Hope Hospital in West Midland, U.K., examined the medical records of 303 breast cancer patients undergoing breast conservation therapy to remove a cancerous lump. They found that 44 percent underwent follow-up surgery because the margins around the tumors were less than 5 millimeters and considered too small. Upon examination of the excised tissues, however, only about 2 percent of those with margins of 2 millimeters or more showed signs of residual cancer.

This meant that with a free margin of 2 millimeters or more, 98 percent of the patients showed no signs of residual cancer, the researchers said.

In addition, they found that the amount of residual disease decreased as the margin increased: 35.3 percent of the women who underwent surgery for invasive breast cancer had residual cancer with no margin, compared to 2.4 percent with a margin of more than 2 millimeters.

"Our results clearly show a relationship between the width of the free margin and the likelihood of finding residual disease at further surgery," the researchers wrote. "To minimize the risk of residual disease, we would recommend aiming for a free margin from invasive tumor of 2 millimeters."

However, the study authors noted that the findings did not apply to women with a precancerous condition known as ductal carcinoma in situ (DCIS). One-third of the patients with DCIS had residual disease even with a free margin up to 5 millimeters. "The equivalent free margin for DCIS remains unknown," they wrote.

Brawley said surgeons may someday embrace 2-millimeter margins around malignant tumors and perform fewer follow-up surgeries as a result. "But it'll be a while before people gravitate to it," he said.

More information

The U.S. National Library of Medicine has more on breast cancer.

-- Randy Dotinga

SOURCE: International Journal of Clinical Practice, Oct. 20, 2010; Otis Brawley, M.D., chief medical officer, American Cancer Society; press release, Oct. 18,

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. $4.37 million NCI grant accelerates recent laboratory finding in Ewings sarcoma
2. Encouraging findings suggest new avenues for treating liver disease in overweight Americans
3. Latest Findings Back Mammograms for Women in Their 40s
4. National committee releases findings on transforming and improving the nursing profession
5. Study findings show value of dietary supplement SAMe in treatment of adults with major depressive disorders
6. Scientists closer to finding what causes the birth of a fat cell
7. New findings further clarify breast cancer risk with hormone therapy
8. Mayo Clinic researchers share latest findings in CT radiation dose reduction efforts
9. U. Iowa biologists publish findings on cell interactions
10. Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course
11. Tel Aviv University Fertility Research Confirms New York Center's DHEA Findings
Post Your Comments:
Related Image:
New Finding Suggests Safe Surgical Margins When Removing Breast Cancers
(Date:10/13/2015)... ... October 13, 2015 , ... Vision Group Holdings, the largest LASIK provider in ... brands including The LASIK Vision Institute and TLC Laser Eye Centers, Vision Group Holdings ... laser vision correction. , Global Laser Vision will continue to operate in San Diego ...
(Date:10/13/2015)... ... October 13, 2015 , ... PhyMed Healthcare Group ... announced its partnership with WPC Healthcare , a provider of predictive analytics ... the data into an aggregated data repository necessary to perform reporting and analytics ...
(Date:10/13/2015)... ... October 13, 2015 , ... Symposium Chairman, Dr. Rod J. ... Dallas Cosmetic Symposium to be held March 2nd and 3rd, 2016. The annual meeting, ... plastic surgeons and cosmetic physicians from around the world. , Key topics at this ...
(Date:10/13/2015)... ... October 13, 2015 , ... e-con Systems Inc., a leading embedded design ... the industry’s first RGB-IR pixel format camera with a USB 3.0 interface and ... See3CAM family of UVC USB 3.0 cameras, is based on the 1/3-inch OV4682 - ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... today their Title Sponsorship of Synergy 2015. The annual WennSoft KEY2ACT user conference ... Valley Ranch and will unite customers, partners, WennSoft team members and sponsors to ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015 WuXi PharmaTech ... and technology platform company serving the pharmaceutical, biotechnology, ... has launched a mobile version of OncoWuXi, the ... to access oncology models and data on the ... and at any time to identify relevant tumor ...
(Date:10/13/2015)...  The Wyss Institute for Biologically Inspired ... launch of its latest startup company, ... reagents providing super-resolution capabilities on standard single-molecule ... instruments. The announcement follows a worldwide licensing ... Development (OTD) and Ultivue for the ...
(Date:10/13/2015)... 13, 2015 --> ... be expected from the Asthma and COPD Therapies market? Which ... Visiongain ,s brand new report shows you potential revenues to ... 309-page report provides 260 tables, charts, and graphs. Discover the ... prospects. Our new study lets you assess forecasted sales at ...
Breaking Medicine Technology: